Esophageal Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI]-Recurrent Esophageal Cancer All recurrent esophageal cancer patients present difficult problems in palliation. All patients, whenever possible, should be considered candidates for clinical trials as outlined in treatment overview.

Standard treatment options:

Recommended Related to Cancer

Overview

This complementary and alternative medicine (CAM) information summary provides an overview of the use of antineoplastons as treatments for people with cancer. The summary includes a brief history of the development of antineoplastons; a review of laboratory, animal, and human studies; and possible side effects associated with antineoplaston use.This summary contains the following key information: Antineoplastons are drugs composed of chemical compounds that are naturally present in the urine...

Read the Overview article > >

• Palliative use of any of the standard therapies, including supportive care.

Treatment options under clinical evaluation:

• Clinical trials.

Current Clinical Trials

Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with recurrent esophageal cancer. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.

General information about clinical trials is also available from the NCI Web site.

In this article